Scarica l'app Stockscreener
16.36
2.91%
-0.49
Dopo l'orario di chiusura:
16.58
0.22
+1.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BEAM Giù?
Forum
Previsione
Precedente Chiudi:
$16.85
Aprire:
$16.87
Volume 24 ore:
1.90M
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.66B
Reddito:
$352.57M
Utile/perdita netta:
$-143.01M
Rapporto P/E:
-9.0387
EPS:
-1.81
Flusso di cassa netto:
$-153.40M
1 W Prestazione:
-1.68%
1M Prestazione:
-17.91%
6M Prestazione:
-39.65%
1 anno Prestazione:
-39.05%
Intervallo 1D:
$16.27
$17.01
Intervallo di 1 settimana:
$16.27
$17.64
Portata 52W:
$13.53
$35.25
Beam Therapeutics Inc Stock (BEAM) Company Profile
Nome
Beam Therapeutics Inc
Settore
Industria
Telefono
857-327-8775
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta BEAM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
16.36 | 1.70B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-03-10 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-08 | Downgrade | Jefferies | Buy → Hold |
| 2023-10-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | Iniziato | Bernstein | Mkt Perform |
| 2023-02-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-20 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | Iniziato | Citigroup | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Market Perform |
| 2022-04-28 | Iniziato | Credit Suisse | Neutral |
| 2022-01-05 | Iniziato | Guggenheim | Buy |
| 2021-10-19 | Iniziato | SVB Leerink | Outperform |
| 2021-09-24 | Ripresa | Stifel | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Redburn | Buy |
| 2021-05-04 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-02-16 | Iniziato | Wells Fargo | Overweight |
| 2021-01-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-01-06 | Iniziato | Stifel | Hold |
| 2020-08-05 | Iniziato | William Blair | Outperform |
| 2020-03-02 | Iniziato | Barclays | Overweight |
| 2020-03-02 | Iniziato | JP Morgan | Overweight |
| 2020-03-02 | Iniziato | Jefferies | Buy |
| 2020-03-02 | Iniziato | Wedbush | Outperform |
Mostra tutto
Beam Therapeutics Inc Borsa (BEAM) Ultime notizie
Beam Therapeutics Inc. stock trendline breakdownWeekly Profit Analysis & High Return Stock Watch Alerts - Newser
Analyzing net buyer seller activity in Beam Therapeutics Inc.Trade Exit Summary & Detailed Earnings Play Alerts - Newser
What MACD and RSI say about Beam Therapeutics Inc.Weekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Is Beam Therapeutics Inc. stock bottoming outMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Can trapped investors hope for a rebound in Beam Therapeutics Inc.2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
Risk adjusted return profile for Beam Therapeutics Inc. analyzed2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Beam Therapeutics Inc. stock outlook for YEAR2025 Key Highlights & Smart Swing Trading Alerts - Newser
Intraday pattern recognizer results for Beam Therapeutics Inc.Weekly Trend Summary & Community Shared Stock Ideas - Newser
Applying Wyckoff theory to Beam Therapeutics Inc. stockEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Chart based analysis of Beam Therapeutics Inc. trends2025 Price Targets & Low Risk Growth Stock Ideas - Newser
Understanding Beam Therapeutics Inc.’s price movementEntry Point & Short-Term Trading Opportunity Alerts - Newser
Sentiment analysis tools applied to Beam Therapeutics Inc.Earnings Risk Report & Community Verified Swing Trade Signals - Newser
Using flow based indicators on Beam Therapeutics Inc.CEO Change & Daily Profit Maximizing Tips - Newser
Intraday pattern recognizer results for Beam Therapeutics IncJuly 2025 Reactions & Daily Profit Focused Stock Screening - Newser
How to contact the Daily Bulletin - FinancialContent
What high frequency data says about Beam Therapeutics Inc.Rate Hike & Growth Oriented Trading Recommendations - Newser
Market reaction to Beam Therapeutics Inc.’s recent newsMarket Performance Summary & Fast Entry High Yield Stock Tips - Newser
Chart based exit strategy for Beam Therapeutics Inc.July 2025 Decliners & Community Trade Idea Sharing Platform - Newser
Is Beam Therapeutics Inc. forming a reversal pattern2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
Combining price and volume data for Beam Therapeutics Inc.Breakout Watch & Safe Swing Trade Setups - Newser
How to manage a losing position in Beam Therapeutics Inc.Short Setup & Accurate Entry/Exit Alerts - Newser
Tools to assess Beam Therapeutics Inc.’s risk profileWeekly Volume Report & Growth Focused Investment Plans - Newser
Can trapped investors hope for a rebound in Beam Therapeutics Inc2025 Major Catalysts & Community Trade Idea Sharing - Newser
Best data tools to analyze Beam Therapeutics Inc. stockEarnings Miss & Community Supported Trade Ideas - Newser
What does recent volatility data suggest for Beam Therapeutics Inc.2025 Retail Activity & Community Verified Swing Trade Signals - Newser
Beam Therapeutics Inc Azioni (BEAM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Beam Therapeutics Inc Azioni (BEAM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Simon Amy | Chief Medical Officer |
Jul 03 '25 |
Sale |
20.12 |
876 |
17,625 |
64,864 |
| Simon Amy | Chief Medical Officer |
Jul 01 '25 |
Sale |
16.94 |
374 |
6,336 |
65,740 |
| Bellon Christine | Chief Legal Officer |
Apr 01 '25 |
Sale |
18.35 |
5,674 |
104,122 |
117,294 |
| Evans John M. | CEO |
Apr 01 '25 |
Sale |
18.35 |
30,663 |
562,684 |
986,249 |
| Ciaramella Giuseppe | President |
Apr 01 '25 |
Sale |
18.35 |
7,434 |
136,418 |
190,216 |
| Cavanagh Bethany J | SVP, Finance and Treasurer |
Apr 01 '25 |
Sale |
18.35 |
3,015 |
55,330 |
44,512 |
| Simon Amy | Chief Medical Officer |
Apr 02 '25 |
Sale |
17.73 |
20,997 |
372,294 |
65,742 |
| Simon Amy | Chief Medical Officer |
Apr 01 '25 |
Sale |
18.35 |
9,566 |
175,542 |
86,739 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):